← All stocks

NovaBridge Biosciences

NBP Net selling

CIK 0001778016 #3889 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$82.50K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$82.50K

2 of 2 sales

Net

−$82.50K

−$82.50K against sales at will

By person

5 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cao Sean Wuxiong

Chief Bus. Development Officer

—

$79.90K (1)

−$79.90K

266,467

0.1004%

$197.19K

+371.9%

Xu Cong Claire

EVP, Clinical Development

—

$2.59K (1)

−$2.59K

304,201

0.1146%

$225.11K

+7.0%

Hagler Mark Arnold

Chief Commercial Officer

—

230,000

0.0867%

$170.20K

—

Dennis Phillip Andrew

Chief Medical Officer

—

157,941

0.0595%

$116.88K

+10.6%

Lenz Robert A.

Director

—

17,218

0.0065%

$12.74K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 4

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 365,972

History held since 28 Apr 2026